Executive Summary: Next Generation Oral Airway (NGOA) 

 

​ The Patented Product: A Fundamental Improvement in Airway Management

 

The Next Generation Oral Airway (NGOA) is a patented, single-use oral pharyngeal airway (OPA) designed to overcome the primary design flaw of legacy OPAs. Manufactured from medical-grade polymer, its key innovation is a longitudinal central split. This allows the device to gently part around the midline anatomy of the tongue and, most critically, the epiglottis, rather than depressing it.

This simple yet profound design change directly addresses a well-known clinical problem that has been tolerated for over 80 years. The product is protected by U.S. Patent.

 

Clear Advantages Over the Legacy Product (Guedel Airway)

 

The Guedel airway, the standard of care since the 1940s, has a rigid central curve that directly presses on the midline of the tongue and epiglottis.  This is a known trigger for serious complications in patients who are not deeply anesthetized, particularly during emergence or sedation. It was designed for use in General Anesthesia to block biting of the Endotracheal Tube and airway obstruction and allowing suctioning of the airway.

The NGOA's advantages are directly tied to mitigating these risks:

• Enhanced Patient Safety: By avoiding direct stimulation of the epiglottis and base of the tongue, the NGOA is designed to significantly reduce the incidence of:

  • Gagging, coughing, and vomiting: Mitigates the risk of pulmonary aspiration, a serious and costly complication.

  • Laryngospasm: Avoids a potentially life-threatening airway emergency that requires immediate intervention.

• Smoother Emergence (awakening) from Anesthesia: Provides a more stable and less stimulating airway during the critical transition from anesthesia to consciousness, potentially reducing time and required interventions in the Post-Anesthesia Care Unit (PACU).

• Improved Clinician Experience: Reduces provider stress by minimizing the risk of "fighting the airway," allowing for more controlled and predictable patient recoveries.

• Maintained Functionality: The design maintains all essential functions of a traditional OPA, including bite protection and providing a clear channel for suctioning.

In short, the NGOA moves the OPA from a crude, stimulating tool to an anatomically considerate device, improving the standard of care.

 

Potential Economic & Strategic Value

 

The economic value is driven by market size, premium product positioning, and cost avoidance. This product represents a compelling opportunity for a company like yours.

• Massive, Undisrupted Market: The Guedel airway is a ubiquitous, high-volume product used in nearly every operating room, emergency department, and EMS vehicle globally. The estimated annual U.S. market alone exceeds 50-70 million units. This is a vast market that has seen virtually no innovation.

• Clear Value Proposition for Premium Pricing: While the Guedel is a commodity item, the NGOA's safety features justify a premium price point. The value proposition is not the device itself, but the avoidance of costly complications:

  • A single incident of aspiration pneumonia can increase hospital costs by over $20,000 and significantly extend the length of stay.

  • Reducing PACU time and intervention intensity leads to direct, measurable cost savings and improved patient throughput.

• Strategic "Tuck-In" Product: For a company with an existing sales channel calling on anesthesiologists, CRNAs, and emergency physicians, the NGOA is a perfect tuck-in product. It leverages existing customer relationships and distribution networks, requiring minimal incremental sales and marketing costs.

• Defensible Market Position: The patent provides a strong competitive moat, allowing a new entrant to capture a significant share of the market without immediate "me-too" competition. There are further possibly patentable modifications of the NGOA  which may extend patent protection to the EU, Australia, Canada, etc.  

 

After testing the device, this innovation appears to represent a rare opportunity to disrupt a large, stagnant medical device category with a product that offers clear benefits to patients, clinicians, and hospitals. 

​​

Second Business Opportunity: Customized 3D Printed Oral Device for Sleep Apnea

 

Building on the innovation of the bifurcated oral airway, the second business opportunity focuses on a highly personalized solution for individuals suffering from obstructive sleep apnea (OSA). This product involves the development and commercialization of custom-fitted oral devices that are individually designed for each patient using advanced 3D printing technology.

Unlike standard, off-the-shelf solutions, this tailored approach ensures maximum comfort, retention, and effectiveness. The personalized fit leads to higher patient compliance, fewer side effects (such as jaw pain or tooth movement), and better long-term outcomes.

This offering is especially attractive to dental sleep specialists, sleep clinics, and ENT professionals looking for high-quality, patient-specific solutions. It aligns with current trends toward personalization in healthcare and leverages growing advancements in digital dentistry and additive manufacturing.